Stock Quote
Integrated Pharmaceuticals, Inc. (INTP.PK) (USA Pink Sheets)
$0.00
18 Nov 2009
+0.00%
$0.00
$0.00
86,175
$0.00
$0.00
$0.02
$0.00
0.22
22,073
No news stories for this company within the last 30 days.
INTP.PK
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Featherston, Peter | President, Director | 14,537 |
| Smith, David | Chief Financial Officer, Director | -- |
| Chatterjee, Nilu | Vice President - Research & Development, Director | -- |
Profile
Integrated Pharmaceuticals, Inc. is a development-stage company. As of June 30, 2008, the Company is engaged in the development of clinically active pharmaceutical compounds, including active small molecules and recombinant deoxyribonucleic acid (DNA) technology derived products.
Company Web Links
Company Address
Integrated Pharmaceuticals, Inc.
310 Authority Drive
Fitchburg
P: +971978.6960020
F: +971978.6960026
310 Authority Drive
Fitchburg
P: +971978.6960020
F: +971978.6960026
Analyst Research
| INTP.PK | Industry | |
|---|---|---|
| P/E(TTM) | -- | 12.80 |
| P/S(TTM) | 4.36 | 29.90 |
| ROI(TTM) | -190.70 | 2.35 |
| ROE(TTM) | -190.70 | 3.59 |
No consensus estimates data available.
| Total Revenue | $0.00M |
| Net Income | $-0.44M |
| EPS | $-0.01 |
